Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn

ClinicalTrials.gov ID: NCT00627016

Public ClinicalTrials.gov record NCT00627016. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 5:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Multicenter, Randomized, Double-Blind, Parallel Group, Placebo Controlled Trial to Evaluate the Efficacy of TAK-390MR (30 mg QD) Compared to Placebo on Relief of Nocturnal Heartburn in Subjects With Symptomatic Gastroesophageal Reflux Disease (GERD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether Dexlansoprazole once daily (QD) is effective in treating patients with night heartburn.

Study identification

NCT ID
NCT00627016
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Takeda
Industry
Enrollment
305 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2008 (Type not available)
Primary completion
Mar 2009 (Actual)
Completion
Mar 2009 (Actual)
Last update posted
Apr 28, 2011

2008 – 2009

United States locations

U.S. sites
43
U.S. states
22
U.S. cities
43
Facility City State ZIP Site status
Not listed Tucson Arizona — —
Not listed Anaheim California — —
Not listed Garden Grove California — —
Not listed Lancaster California — —
Not listed Oakland California — —
Not listed San Diego California — —
Not listed Sherwood California — —
Not listed Westlake Village California — —
Not listed Jupiter Florida — —
Not listed Miami Florida — —
Not listed New Smyrna Beach Florida — —
Not listed Ocala Florida — —
Not listed St. Petersburg Florida — —
Not listed Zephyrhills Florida — —
Not listed Moline Illinois — —
Not listed Clive Iowa — —
Not listed Wichita Kansas — —
Not listed Metairie Louisiana — —
Not listed Prince Frederick Maryland — —
Not listed Jefferson City Missouri — —
Not listed Egg Harbor Town New Jersey — —
Not listed Great Neck New York — —
Not listed Greensboro North Carolina — —
Not listed Harrisburg North Carolina — —
Not listed Winston-Salem North Carolina — —
Not listed Mogadore Ohio — —
Not listed Oklahoma City Oklahoma — —
Not listed Portland Oregon — —
Not listed Duncansville Pennsylvania — —
Not listed Bristol Tennessee — —
Not listed Chattanooga Tennessee — —
Not listed Johnson City Tennessee — —
Not listed Kingsport Tennessee — —
Not listed Nashville Tennessee — —
Not listed El Paso Texas — —
Not listed Fort Worth Texas — —
Not listed Houston Texas — —
Not listed Odessa Texas — —
Not listed San Antonio Texas — —
Not listed Ogden Utah — —
Not listed Norfolk Virginia — —
Not listed Spokane Washington — —
Not listed Monroe Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00627016, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 28, 2011 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00627016 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →